$1.74
$-0.01 (-0.57%)
End-of-day quote: 02/17/2024
NasdaqCM:GALT

Galectin Therapeutics Stock Price

0
Underperform
1
2
3
4
5
6
7
8
9
10
1M 3M YTD 1Y 2Y 5Y 10Y 20Y
P/E Ratio
15.0
Market Cap
0.10B
Price-to-book Ratio
0
Earnings
05/14/2024
Dividend
$0.00
Div Yld
0.00%
Dividend Growth
0 Years
Beta
0.94
Short Interest
3.42%
Forecast 1Y
0.00%
Analyst Price Target
$11.00
LTG 5Y
0.00%
52 week range
$1.08 - $2.47